Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

Seres Therapeutics (MCRB) Times Interest Earned (2020 - 2024)

Seres Therapeutics' Times Interest Earned history spans 5 years, with the latest figure at $46.66 for Q4 2024.

  • For Q4 2024, Times Interest Earned changed N/A year-over-year to $46.66; the TTM value through Sep 2025 reached $167.36, up 147.2%, while the annual FY2023 figure was -$79.05, 164.51% down from the prior year.
  • Times Interest Earned for Q4 2024 was $46.66 at Seres Therapeutics, up from -$55.72 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $91.94 in Q3 2021 and bottomed at -$66.98 in Q4 2021.
  • The 5-year median for Times Interest Earned is -$34.23 (2022), against an average of -$21.4.
  • The largest YoY upside for Times Interest Earned was 323.77% in 2021 against a maximum downside of 184.05% in 2021.
  • A 5-year view of Times Interest Earned shows it stood at -$23.58 in 2020, then tumbled by 184.05% to -$66.98 in 2021, then surged by 98.63% to -$0.92 in 2022, then surged by 1915.67% to $16.72 in 2023, then soared by 179.11% to $46.66 in 2024.
  • Per Business Quant, the three most recent readings for MCRB's Times Interest Earned are $46.66 (Q4 2024), -$55.72 (Q1 2024), and $16.72 (Q3 2023).